advertisement
PLoS ONE 211
Showing records 1 to 25 | Display all abstracts in PLoS ONE126219 Glaucoma detection and staging from visual field images using machine learning techniques
Akter N
PLoS ONE 2025; 20: e0316919
125900 Visual impairment in any eye adversely affects quality of life: Psychometric validation of the Malay NEI VFQ-25
Loke JY
PLoS ONE 2025; 20: e0324979
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Sangchocanonta S
PLoS ONE 2025; 20: e0314111
126332 Influence of artificial intelligence on ophthalmologists' judgments in glaucoma
Kashiwagi K
PLoS ONE 2025; 20: e0321368
126460 Microglia remodeling in the visual thalamus of the DBA/2J mouse model of glaucoma
Thompson JL
PLoS ONE 2025; 20: e0323513
126336 Virtual reality perimetry compared to standard automated perimetry in adults with glaucoma: A systematic review
Hekmatjah N
PLoS ONE 2025; 20: e0318074
126602 Optical coherence tomography angiography and progressive retinal nerve fiber layer loss in mild to moderate open-angle glaucoma
Pradhan ZS
PLoS ONE 2025; 20: e0319903
125902 Finite element analysis of the lens profile during accommodation
Schachar RA
PLoS ONE 2025; 20: e0317740
125857 Leveraging molecular-QTL co-association to predict novel disease-associated genetic loci using a graph convolutional neural network
Ng-Kee-Kwong J
PLoS ONE 2025; 20: e0324183
126241 In vivo imaging of mitochondrial function in normal, glaucoma suspect, and glaucoma eyes
Caro R
PLoS ONE 2025; 20: e0317354
126039 Inhibition of VE-PTP rejuvenates Schlemm's canal in aged mice and acts via Tie2
Mishra S
PLoS ONE 2025; 20: e0323615
126354 First-line glaucoma monotherapy medication patterns in Finland during 1995-2019 based on a population-based study
Purola PKM
PLoS ONE 2025; 20: e0316835
126166 Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review
Prinz J
PLoS ONE 2025; 20: e0314644
126333 Lived experiences and coping strategies of people living with Glaucoma in Nigeria: A qualitative study
Ibanga AA
PLoS ONE 2025; 20: e0325258
124941 Incidence of and factors associated with brimonidine allergy
Chansangpetch S
PLoS ONE 2025; 20: e0325319
126587 Relationship between nocturnal blood pressure dip and β-parapapillary atrophy zone choroidal vessel density in normal-tension glaucoma patients
Park J
PLoS ONE 2025; 20: e0317468
126019 Transient ocular hypertension remodels astrocytes through S100B
Huang W
PLoS ONE 2025; 20: e0313556
126263 Association of myopia and parapapillary choroidal microvascular density in primary open-angle glaucoma
Suwan Y
PLoS ONE 2025; 20: e0317881
126386 Optimizing deep learning models for glaucoma screening with vision transformers for resource efficiency and the pie augmentation method
Sangchocanonta S
PLoS ONE 2025; 20: e0314111
126354 First-line glaucoma monotherapy medication patterns in Finland during 1995-2019 based on a population-based study
Purola PKM
PLoS ONE 2025; 20: e0316835
125858 Safety of lifitegrast: A real-world pharmacovigilance study based on FAERS
Zhang C
PLoS ONE 2025; 20: e0321307
126364 Pupil responses to melanopsin-isolating stimuli as a potential diagnostic biomarker for glaucoma
Denniss J
PLoS ONE 2025; 20: e0324373
126291 Changes in individuals' glaucoma progression velocity after IOP-lowering therapy: A systematic review
Naik V
PLoS ONE 2025; 20: e0324806
126778 Investigating the miRNA-mRNA interactome of human trabecular meshwork cells treated with TGF-β1 provides insights into the pathogenesis of pseudoexfoliation glaucoma
Roodnat AW
PLoS ONE 2025; 20: e0318125
126067 Prevalence and causes of blindness and vision impairment among people 50 years and older in Nepal: A national Rapid Assessment of Avoidable Blindness survey
Kumar Mishra S
PLoS ONE 2025; 20: e0309037
